Skip to content

Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight

RENEW: Reach Out to Enhance Wellness in Older Survivors

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00303875
Enrollment
641
Registered
2006-03-17
Start date
2003-12-31
Completion date
2009-05-31
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colorectal Cancer, Prostate Cancer

Keywords

recurrent prostate cancer, stage I prostate cancer, stage IIB prostate cancer, stage IIA prostate cancer, stage III prostate cancer, stage IV prostate cancer, recurrent breast cancer, stage I breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer, stage IV breast cancer, recurrent colon cancer, stage I colon cancer, stage II colon cancer, stage III colon cancer, stage IV colon cancer, recurrent rectal cancer, stage I rectal cancer, stage II rectal cancer, stage III rectal cancer, stage IV rectal cancer

Brief summary

RATIONALE: Exercise and dietary counseling may improve physical activity, nutrition, and quality of life in older long-term cancer survivors who are overweight. PURPOSE: This randomized clinical trial is studying two different schedules of exercise and dietary counseling to compare how well they work in improving physical activity, nutrition, and quality of life in older long-term cancer survivors who are overweight.

Detailed description

OBJECTIVES: Primary * Compare the physical function over 1 year of overweight older long-term cancer survivors assigned to immediate vs delayed exercise and dietary counseling. Secondary * Compare physical activity, saturated fat and vegetable and fruit intake, body mass index, depression, and general health and well being of experimental arm patients vs control arm patients. * Evaluate self-efficacy, social support, comorbidity, cancer-type, and gender as factors associated with program efficacy. * Determine the functional decline over a 2-year period in patients who undergo immediate vs delayed intervention. * Characterize the mathematical form, over a 2-year period, of physical functioning trajectories among older cancer survivors, including determining if the intervention effects are durable in those who receive the intervention initially and whether catch-up is possible in the delayed intervention arm. OUTLINE: This is a randomized study. Patients are stratified according to cancer type (colorectal vs breast or prostate), sex, age (65-74 years vs 75 years and over), and race (white vs non-white). Patients are randomized to 1 of 2 intervention arms. * Arm I (immediate intervention): Patients receive a personalized notebook of diet and exercise information, exercise equipment, and logbooks to record food intake and exercise behaviors. Patients undergo 20-minute telephone discussions with a health counselor once weekly for 3 weeks, every 2 weeks for 2 months, and then monthly for up to 1 year for a total of 15 sessions. Patients also undergo a 5-minute telephone survey to assess health every 3 months. * Arm II (delayed intervention): Patients undergo intervention as in arm I after a 1-year waiting period. After completion of study intervention, patients are followed periodically for up to 2 years. PROJECTED ACCRUAL: A total of 640 patients will be accrued for this study.

Interventions

BEHAVIORALbehavioral dietary and exercise intervention

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to 120 Years
Healthy volunteers
No

Inclusion criteria

DISEASE CHARACTERISTICS: * Diagnosed colorectal, prostate, or female breast cancer * At least 5 years beyond date of diagnosis with no clinical evidence of progressive disease or second primaries * Body mass index ≥ 25 kg/m\^2 and \< 40 kg/m\^2 * Currently exercising \< 150 minutes/week * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Menopausal status not specified * No serious intercurrent medical condition or disability that could preclude study treatment, including any of the following: * Severe orthopedic condition or scheduled hip or knee replacement within the next 6 months * Paralysis * End-stage renal disease * Dementia * Unstable angina * Heart attack, congestive heart failure, or pulmonary condition that required oxygen or hospitalization within the past 6 months * Ability to read, write, and speak English PRIOR CONCURRENT THERAPY: * No concurrent warfarin

Design outcomes

Primary

MeasureTime frameDescription
Physical function as assessed by Short-Form Health Survey (SF-36) with physical function subscale and late effects lower body subscales at baseline and years 1 and 2 following study completionone yearone year for intervention subjects - in year two, wait listed controls received intervention and the intervention subjects were followed.

Secondary

MeasureTime frameDescription
Physical activity as assessed by Community Healthy Activities Model Program for Seniors (CHAMPS) at baseline and years 1 and 2 following study completionone yearone year for intervention subjects - in year two, wait listed controls received intervention and the intervention subjects were followed.
Dietary intake as assessed by 2-day dietary recalls at baseline and years 1 and 2 following study completionone yearone year for intervention subjects - in year two, wait listed controls received intervention and the intervention subjects were followed.
Body weight status as assessed by body mass index at baseline and years 1 and 2 following study completionone yearone year for intervention subjects - in year two, wait listed controls received intervention and the intervention subjects were followed.
Quality of life as assessed by SF-36 at baseline and years 1 and 2 following study completionone yearone year for intervention subjects - in year two, wait listed controls received intervention and the intervention subjects were followed.
Self-efficacy for exercise and dietary change assessed by self-efficacy algorithms at baseline and years 1 and 2 following study completionone yearone year for intervention subjects - in year two, wait listed controls received intervention and the intervention subjects were followed.
Stage of readiness for exercise and dietary change as assessed by the stage of change algorithms at baseline and years 1 and 2 following study completionone yearone year for intervention subjects - in year two, wait listed controls received intervention and the intervention subjects were followed.
Depression and/or anxiety as assessed by Hospital Anxiety Depression Scale at baseline and years 1 and 2 following study completionone yearone year for intervention subjects - in year two, wait listed controls received intervention and the intervention subjects were followed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026